Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization - Lai, T Y; Luk, F O; Lee, G K (Eye (Lond), 2012)